Skip to content
10-Q

Quarterly Report

Odonate Therapeutics, Inc.

0001564590-20-034522

← back to feed
Filed
Jul 30, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jul 17, 2020 32.13M sh
Current Liabilities Q2 2020 · Jun 30, 2020 $25.56M
Current Liabilities Q2 2020 · Dec 31, 2019 $24.78M
Total Liabilities Q2 2020 · Jun 30, 2020 $27.18M
Total Liabilities Q2 2020 · Dec 31, 2019 $26.53M
Current Assets Q2 2020 · Jun 30, 2020 $127.81M
Current Assets Q2 2020 · Dec 31, 2019 $183.93M
Total Assets Q2 2020 · Jun 30, 2020 $132.73M
Total Assets Q2 2020 · Dec 31, 2019 $188.83M
Stock Issued Q2 2020 · Jul 2, 2019 712.5K sh
Stock Issued Q2 2020 · Jun 28, 2019 4.75M sh
Capex Q2 2020 · Jun 30, 2019 $103K
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$50.33M
Cash And Equivalents Q2 2020 · Jun 30, 2019 $207.16M
Cash And Equivalents Q2 2020 · Dec 31, 2018 $139.3M
Stockholders Equity Q2 2020 · Jun 30, 2019 $190.86M
Stockholders Equity Q2 2020 · Mar 31, 2019 $98.44M
Stockholders Equity Q2 2020 · Dec 31, 2018 $124M
Sga Expense Q2 2020 · Jun 30, 2019 $2.78M
Sga Expense Q2 2020 · Jun 30, 2019 $5.37M
Rd Expense Q2 2020 · Jun 30, 2019 $26.45M
Rd Expense Q2 2020 · Jun 30, 2019 $53.08M
Net Income Q2 2020 · Jun 30, 2019 −$28.7M
Net Income Q2 2020 · Jun 30, 2019 −$57.35M
Net Income Q2 2020 · Mar 31, 2019 −$28.65M
Operating Income Q2 2020 · Jun 30, 2019 −$29.24M
Operating Income Q2 2020 · Jun 30, 2019 −$58.46M